At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 100 enrolled
Drug / intervention
Test Product 1 +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Triple-blind, Comparator Controlled, Parallel Clinical Trial to Study the Efficacy and Safety of Three Test Products and Comparator on Muscular Performance in a Healthy, Sedentary Adult Population After the Initiation of a Resistance Training Program
In Brief
A Phase 2 clinical trial evaluating Test Product 1, Test Product 2, and 2 other interventions for Muscle Strength. Completed, enrolled 100 participants across 1 site.
Detailed Summary
The objective of this randomized, triple-blind, comparator controlled, parallel clinical trial is to investigate the functional equivalence of three test products compared to whey protein on muscular performance in a healthy, sedentary adult population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMuscle Strength
CountriesCanada
Collaborators--
Timeline
Phase 2CompletedFinished
20222023202420252026
First PostedMar 2021
Enrollment StartApr 2021
Primary CompletionApr 2022
TodayJul 2026
First PostedMar 24, 2021
Enrollment StartApr 1, 2021
Primary CompletionApr 18, 2022
TodayJul 1, 2026
Enrollment to primary: 1.0 yearsPosted 5.3 years ago
Interventions
Test Product 1other
Pea Protein powder
Test Product 2other
Pea \& Oat Protein Powder
Test Product 3other
Oat Protein Powder
Comparatorother
Whey Protein Isolate